WESAIL Biotech Co., Ltd has introduced a new CE-IVD Antigen Test Kit to its COVID-19 (SARS-CoV-2) product series after launching the IgM/IgG Antibody Test Kit early this year. Industry partners can apply for both product samples NOW for NO CHARGE via FREE SAMPLE.

With reports of the recent resurgence of COVID-19 in many parts of the world, the global IVD market is seeing increasing demand for COVID-19 testing.

A new trend has also been formed in the application of COVID-19 screening and control; shifting from antibody tests to antigen tests, as government agencies continuously increase orders for COVID-19 Ag Tests from diagnostic companies.

To accommodate this change, the WESAIL COVID-19 Antigen Test Kit was launched, with performances that extend beyond industry standards.

Features of WESAIL COVID-19 CE-Marked 15 Min Antigen Test Kit (Awaiting FDA-EUA)

• 90% sensitivity & 98% specificity


• LoD = 8x10² TCID₅₀/mL


• Result in 15 min


• Rapid detection of SARS-CoV-2 N-protein


• Indication of acute & early infections


• For nasopharyngeal or nasal swabs and viral transport media samples


• Individual & 20 test packages available (for different applications)

Features of WESAIL COVID-19 IgM/IgG Antibody Test

• 99% specificity & ≥90% sensitivity


• Result in 6 min


• Rapid detection of IgM & IgG antibodies in one single test


• Indication of both recent and previous infections


• No equipment needed, visual interpretation of results


• Easy operation, compatible with whole blood/serum/plasma/peripheral blood


• Individual & 20 test packages available (for different applications)